Journal Report

Drug Safety

Download PDF
Journal Information
Journal Title
Drug Safety
Publisher
Adis
ISSN
0114-5916
E-ISSN
1179-1942
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Disproportionality Analysis Signal Detection Using the New ‘Information Component–Bicluster–Bayesian Hierarchical Model’
Hannah Johnson, Maria Loane, Helen Dolk et al.
2026-10-29
DOI: 10.1007/s40264-026-01736-9
Correction: Medications and Glucose-6-Phosphate Dehydrogenase Deficiency
Ilan Youngster, Lidia Arcavi, Renata Schechmaster et al.
2026-10-29
DOI: 10.1007/s40264-026-01740-z
Acknowledgement to Referees
2026-10-25
DOI: 10.1007/s40264-026-01744-9
Toward a Framework for Case Identification in Pharmacovigilance: Not All Reports are Created Equal
Michele Fusaroli, Joana Félix China, D. Sartori et al.
2026-10-23
DOI: 10.1007/s40264-026-01743-w
EudraScore: Modification of the Vigi4Eudra-score for the Assessment of the Completeness of Adverse Drug Reaction Reports in EudraVigilance
Diana Dubrall, Patrick Christ, Dennis Lex et al.
2026-10-21
DOI: 10.1007/s40264-026-01720-3
Strengthening Signal Detection by Proactive Adverse Event Case Identification in Electronic Health Records Using a Text-Mining Tool
Gabriëlla von Kreijfelt, Juliëtte Zwaveling, Jette A. van Lint et al.
2026-10-20
DOI: 10.1007/s40264-026-01739-6
Reassessing the Neoplasm Signal with Fezolinetant: Regulatory Inference, Mechanistic Plausibility, and the Case for Proactive Pharmacovigilance
Glen Clack, Jennifer Renwick
2026-10-14
DOI: 10.1007/s40264-026-01737-8
Current Pharmacovigilance Outsourcing Practices in Arab Countries
Ibrahim Abdeldayem, Thamir M Alshammari, Karine Palin
2026-10-14
DOI: 10.1007/s40264-026-01734-x
Disproportionality Analysis of FAERS Data Divergence and a Systematic Review of Comparative Safety Studies: Lessons Learned from the Example of Ranitidine and Cancer Risk
Mahesh Rathod, Maheshwari Kadari, Haripriya R. Mohan et al.
2026-10-10
DOI: 10.1007/s40264-026-01730-1
Switching Patterns of Oral Retinoids to Alternative Medications: An Interrupted Time-Series Analysis of Four European Countries
Judit Riera-Arnau, Shahab Abtahi, Mònica Sabaté Gallego et al.
2026-10-8
DOI: 10.1007/s40264-026-01738-7
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 04:48